0
World
Keytruda – das Milliarden-Märchen eines Pharmakonzerns
April 17, 2026
Scroll
Posted 2 hours ago by
Die Entwicklung des Krebsmedikaments Keytruda soll laut Hersteller 46 Milliarden Dollar gekostet haben. Falsch, sagt die NGO Public Eye. Nach ihren Schätzungen waren es höchstens 4,8 Milliarden Dollar.
Beobachter
Coverage and analysis from Switzerland. All insights are generated by our AI narrative analysis engine.
Switzerland
Bias: center
People's Voices (0)
Leave a comment
0/500
Note: Comments are moderated. Please keep it civil. Max 3 comments per day.